Bruker's Energy & Supercon Technologies division has signed roughly $500 million in multi-year supply agreements with two global healthcare companies for high-performance superconductors used in next-generation MRI magnets.
Bruker Corporation's Energy & Supercon Technologies (BEST) division has announced two multi-year supply agreements worth approximately $500 million in expected future revenue. The deals, one of which extends up to seven years, will see Bruker supply high-performance superconductors to two global healthcare companies for use in their next-generation MRI magnets.
The announcement comes alongside other recent moves from Bruker, including the addition of veteran diagnostics executive Jack J. Phillips to its Board of Directors effective January 1, 2026, and the unveiling of its AVANCE NEO-X NMR console—a modular system supporting liquids, solids, and microimaging—at the ENC 2026 conference in May. Bruker also reported a return to organic revenue growth in its second quarter of 2026, with its Scientific Instruments segment posting 10% organic bookings growth year-over-year.
